Apparatus "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Feb 04, 2026 Feb 04, 2026 Eisai and Biogen have partnered to develop Leqembi and have priced it at $26,500 per year.
